| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.06 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.06 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.098 | 0.06 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |